dcfbc
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01417182)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate carboxypeptidase IIRadiopharmaceutical
FOLH1 radiopharmaceutical
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)CC[C@H](NC(=O)N[C@@H](CSCc1ccc(F)cc1)C(=O)O)C(=O)O- Mol. weight
- 402.4 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1232667 ↗
Also known as
- dcfbc
- dcfbc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01815515 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2013 | Johns Hopkins University |
| NCT01496157 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2011 | Johns Hopkins University |
| NCT01417182 | Phase 1 | Sep 1, 2010 | Johns Hopkins University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 3 | 3 | 2 | 2010 |
1 organizations
Page 1 / 1